IP Library Granted Patent US 9,364,354
Granted Patent B2
US 9,364,354 · App. 14/506,403 · Granted Jun 14, 2016

Methods for treating abnormal growths in the body using a flow reducing implant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,364,354
App. No.
14/506,403
Granted
Jun 14, 2016
Kind
B2
Abstract

A flow reducing implant for reducing blood flow in a blood vessel having a cross sectional dimension, the flow reducing implant comprising a hollow element adapted for placement in the blood vessel defining a flow passage therethrough, said flow passage comprising at least two sections, one with a larger diameter and one with a smaller diameter, wherein said smaller diameter is smaller than a cross section of the blood vessel. A plurality of tabs anchor, generally parallel to the blood vessel wall, are provided in some embodiments of the invention.

Claims (23)

1. An expandable flow-reducing implant for placement in a blood vessel of a patient, the implant comprising:

a narrowed section having first and second ends and defining a flow passage therethrough;

first and second flared sections located at the first and second ends of the narrowed section; and

one or more slits located on the narrowed section and the first and second flared sections,

wherein the one or more slits have a configuration that provides a greater stiffness to the narrowed section than the first and second flared sections, and wherein the one or more slits have a configuration that allows the first and second portions to expand to a diameter larger than the narrowed section.

2. The flow-reducing implant of claim 1 , wherein a diameter of the flow passage is substantially fixed at a size that is predetermined prior to implantation by a configuration of the one or more slits on the narrowed section.

3. The flow-reducing implant of claim 1 , wherein a configuration of the one or more slits on the first and second flared sections allow the first and second flared sections to expand within the blood vessel to a size that firmly affixes the implant within the blood vessel.

4. The flow-reducing implant of claim 1 , wherein the one or more slits on the narrowed section and/or the first and second flared sections are of varying width, thickness, density, length, and/or orientation.

5. The flow-reducing implant of claim 1 , wherein the one or more slits on the narrowed section and/or the first and second flared sections are of varying length.

6. The flow-reducing implant of claim 5 , wherein a length of the one or more slits increases as a function of a distance from a center of the narrowed section.

7. The flow-reducing implant of claim 1 , wherein the one or more slits of the first and second flared sections are on average larger than the one or more slits of the narrowed section.

8. The flow-reducing implant of claim 1 , wherein the one or more slits on the narrowed section and/or the first and second flared sections are non-uniform.

9. The flow-reducing implant of claim 1 , wherein the one or more slits on the narrowed section and/or the first and second flared sections are non-uniform before expansion of the first and second flared sections.

10. The flow-reducing implant of claim 1 , wherein the implant is coated with a biologically inert material.

11. The flow-reducing implant of claim 1 , wherein the one or more slits on the narrowed section and/or the first and second flared sections fill at least 80% of a surface of the flow-reducing implant.

12. The flow-reducing implant of claim 1 , wherein the implant is coated with materials that promote tissue ingrowth.

13. The flow-reducing implant of claim 1 , wherein the narrowed section is configured to decrease blood flow through the blood vessel.

14. The flow-reducing implant of claim 13 , wherein the blood vessel is a coronary sinus.

15. The flow-reducing implant of claim 14 , wherein the decrease in the blood flow through the coronary sinus is sufficient so as to cause angiogenesis.

16. The flow-reducing implant of claim 1 , wherein at least one of the flared sections expands as a result of a balloon expansion catheter.

17. The flow-reducing implant of claim 1 , wherein at least one of the flared sections expands automatically following removal of a restricting element.

18. The flow-reducing implant of claim 1 , wherein the first flared section has a first diameter and the second flared section has a second diameter, wherein the first diameter is larger than the second diameter.

19. The flow-reducing implant of claim 18 , wherein the first and second diameters are governed by the configuration of the one or more slits on the first and second flared sections.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2024
From: NEOVASC MEDICAL LTD.
To: SHOCKWAVE MEDICAL, INC.
Reel/Frame 066942/0164 →
RELEASE OF SECURITY INTEREST Recorded Jun 9, 2020
From: BIO IP VENTURES II LLC, AS COLLATERAL AGENT
To: NEOVASC MEDICAL LTD.
Reel/Frame 052874/0308 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 033937 FRAME: 0900. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 18, 2019
From: BEN-MUVHAR, SHMUEL; SHALEV, ILAN; TSEHORI, JONATHAN; DARVISH, NISSIM
To: NEOVASC MEDICAL LTD.
Reel/Frame 051367/0385 →
DEBENTURE Recorded Apr 27, 2018
From: NEOVASC MEDICAL LTD.
To: BIO IP VENTURES II LLC, AS COLLATERAL AGENT
Reel/Frame 046339/0332 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY COLLATERAL AT REEL/FRAME NO. 41269/0244 Recorded Jan 12, 2018
From: EDWARDS LIFESCIENCES CARDIAQ LLC
To: NEOVASC INC.; NEOVASC TIARA INC.
Reel/Frame 045060/0001 →
SECURITY INTEREST Recorded Jan 5, 2017
From: NEOVASC INC.; NEOVASC TIARA INC.
To: EDWARDS LIFESCIENCES CARDIAQ LLC
Reel/Frame 041269/0244 →